Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Crisaborole ointment 2%
DRUG
3 trials
Sponsors
Pfizer
Conditions
Atopic Dermatitis
Healthy
Phase 1
A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis
Completed
NCT03260595
Pfizer
Atopic Dermatitis, Healthy
Start: 2017-09-13
End: 2017-11-27
Updated: 2019-03-01
Phase 2
Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis
Completed
NCT03954158
Pfizer
Atopic Dermatitis
Start: 2019-06-15
End: 2019-12-16
Updated: 2020-07-14
Phase 4
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Completed
NCT03356977
Pfizer
Atopic Dermatitis
Start: 2018-01-16
End: 2019-04-12
Updated: 2019-10-10
Related Papers
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.
2023-02-22
3 citations
A phase 2b, randomized, double‐blind, multicenter, vehicle‐controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild‐to‐moderate atopic dermatitis
The Journal of Dermatology
2021-08-26
16 citations
Safety Of Crisaborole In Patients Aged 3 To <24 Months With Mild-To-Moderate Atopic Dermatitis
PEDIATRICS
2021-03-01
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
2020-04-01
55 citations